Revenue: The sum of all revenue fields included for a company's operating activities.
Lyra Therapeutics, Inc. (LYRA) had Revenue of $0.18M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$0.18M |
$-7.44M |
|
-- |
|
$0.18M |
|
$9.01M |
|
$-8.83M |
|
$1.39M |
|
$-7.43M |
|
$-7.43M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-8.83M |
|
$-8.70M |
|
1.35M |
|
1.35M |
|
$-5.51 |
|
$-5.51 |
|
| Balance Sheet Financials | |
$31.06M |
|
$1.16M |
|
$21.51M |
|
$52.57M |
|
$11.16M |
|
-- |
|
$39.79M |
|
$50.95M |
|
$1.62M |
|
$1.62M |
|
$1.62M |
|
1.62M |
|
| Cash Flow Statement Financials | |
$-15.43M |
|
$-0.00M |
|
$4.64M |
|
$42.57M |
|
$31.78M |
|
$-10.79M |
|
$1.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4822.95% |
|
-4822.95% |
|
-- |
|
-4062.84% |
|
-4063.93% |
|
$-15.43M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-458.50% |
|
-458.51% |
|
-14.15% |
|
-458.51% |
|
$1.00 |
|
$-11.44 |
|
$-11.44 |
|